The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...

Mavryk Dynamics, the team behind the Mavryk Network, has successfully raised over $5.2M to develop the Layer-1 blockchain ...

Imagine you could control a video game with only your mind.  Now imagine that, while you are playing the video game, your ...

Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.The commercialization was ...

Generative AI chatbots are showing the same cognitive decline as the human brain as they age, studies have shown. Artificial ...

Only 6% of workers say workplace AI use will lead to more job opportunities for them in the long run. About a third (32%) say it will lead to fewer opportunities for them, and 31% say it will not make ...

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

Things took a scary turn last fall when his heart began to fail again. Doctors gave him three months to live. “And that’s ...

A UC San Diego-led team's project to develop next-generation brain implants builds on the development of this transparent ...

Many younger cooks rely on electric sharpeners or professional services, but sharpening knives by hand offers better control ...

On average, 90% of the 4,096 microhole electrodes were intracellularly coupled to neurons on top and were able to record many ...